Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 550 of 923 entries
View as:

Safety and Efficacy of Edoxaban in Thoracoscopic Ablation

Phase: N/A Priority: Normal
NCT ID: NCT04121767 Org: User:
Start: 12/01/17 End: 07/10/20 Due: 07/10/21

Patients Who Refractory Cancer Conqueror for Bio New Drug Development Translational Research Establishment

Phase: N/A Priority: Normal
NCT ID: NCT01932047 Org: User:
Start: 04/30/10 End: 04/30/15 Due: 04/30/16

The Effects of Anesthetics on Persistent Pain Following Breast Cancer Surgery

Phase: N/A Priority: Normal
NCT ID: NCT03782896 Org: User:
Start: 12/31/18 End: 12/30/19 Due: 12/30/20

A Gray Zone Approach of Rotational Thromboelastometry for Predicting Postoperative Bleeding in Cardiac Surgical Patients

Phase: N/A Priority: Normal
NCT ID: NCT01889732 Org: User:
Start: 06/30/13 End: 08/31/13 Due: 08/31/14

Impact of 80 W KTP Laser Vaporization Prostatectomy on Severity of Obstruction in Benign Prostatic Hyperplasia

Phase: N/A Priority: Normal
NCT ID: NCT00908427 Org: User:
Start: 06/30/04 End: 09/30/07 Due: 09/30/08

Study of Docetaxel and Gemcitabine in Metastatic Esophageal Squamous Cell Cancer

Phase: N/A Priority: Normal
NCT ID: NCT01469598 Org: User:
Start: 08/31/11 End: 01/31/15 Due: 01/31/16

Proton Beam Therapy in Hepatocellular Carcinoma With Portal Vein Tumor Thrombosis

Phase: N/A Priority: Normal
NCT ID: NCT02571946 Org: User:
Start: 08/31/15 End: 09/30/21 Due: 09/30/22

The Effect of Ligasure® to Destroy Cornual Portion of Fallopian Tube

Phase: N/A Priority: Normal
NCT ID: NCT01894971 Org: User:
Start: 11/30/12 End: 12/31/14 Due: 12/31/15

Exosome as the Prognostic and Predictive Biomarker in EBC Patients

Phase: N/A Priority: Normal
NCT ID: NCT05955521 Org: User:
Start: 05/01/21 End: 07/01/28 Due: 07/01/29

ABUS for Early-stage Breast Cancer

Phase: N/A Priority: Normal
NCT ID: NCT04607473 Org: User:
Start: 08/15/19 End: 08/15/22 Due: 08/15/23

Study of Pazopanib Monotherapy in Patients With Unresectable, Metastatic Neuroendocrine Tumor

Phase: N/A Priority: Normal
NCT ID: NCT01099540 Org: User:
Start: 04/30/10 End: 03/31/13 Due: 03/31/14

Whole Breast RT on Prone Position in Korean Women

Phase: N/A Priority: Normal
NCT ID: NCT02231112 Org: User:
Start: 11/30/14 End: 09/30/15 Due: 09/30/16

Multicenter Cross Sectional Study of Primary Intestine Lymphoma

Phase: N/A Priority: Normal
NCT ID: NCT01043302 Org: User:
Start: 09/30/08 End: 03/31/10 Due: 03/31/11

Zydena on Cognitive Function of Alzheimer's Disease Patients

Phase: N/A Priority: Normal
NCT ID: NCT01940952 Org: User:
Start: 09/30/13 End: - Due: -

Prospective Cohort for Adult Hemophagocytosis

Phase: N/A Priority: Normal
NCT ID: NCT03117010 Org: User:
Start: 01/01/17 End: 12/31/26 Due: 12/31/27

Effect of Donepezil on the Reorganization of Cognitive Neural Network in Patients With Post-Stroke Cognitive Impairment

Phase: N/A Priority: Normal
NCT ID: NCT00530478 Org: User:
Start: - End: - Due: -

Drug-Coated Balloon Versus Drug-Eluting Stent for Treatment of De-Novo Coronary Lesions in Patients With High Bleeding Risk-2

Phase: N/A Priority: Normal
NCT ID: NCT06742931 Org: User:
Start: 04/07/25 End: 12/31/31 Due: 12/31/32

Endoscopic Ultrasonography-guided Double Ethanol Lavage for Pancreatic Cysts: a Prospective Cohort Study

Phase: N/A Priority: Normal
NCT ID: NCT02213419 Org: User:
Start: 10/31/14 End: 08/31/16 Due: 08/31/17

International Extranodal NK/T-cell Lymphoma Project

Phase: N/A Priority: Normal
NCT ID: NCT02386813 Org: User:
Start: 01/31/13 End: 06/30/15 Due: 06/30/16

Study of Pembrolizumab in Metastatic Biliary Tract Cancer as Second-line Treatment After Failing to at Least One Cytotoxic Chemotherapy Regimen: Integration of Genomic Analysis to Identify Predictive Molecular Subtypes

Phase: N/A Priority: Normal
NCT ID: NCT03110328 Org: User:
Start: 02/07/18 End: 03/24/22 Due: 03/24/23

Safety and Clinical Activity of Lapatinib in Patients With HER2-positive Refractory Advanced Cancer

Phase: N/A Priority: Normal
NCT ID: NCT02342587 Org: User:
Start: 12/03/14 End: 08/21/16 Due: 08/21/17

A Gray Zone Approach to Stroke Volume Variation Derived From NICOM

Phase: N/A Priority: Normal
NCT ID: NCT01898975 Org: User:
Start: 06/30/13 End: 05/31/14 Due: 05/31/15

Prognostic Perspective of Invasive Hyperemic and Non-Hyperemic Physiologic Indices Measured After Percutaneous Coronary Intervention

Phase: N/A Priority: Normal
NCT ID: NCT04265443 Org: User:
Start: 05/13/13 End: 10/01/22 Due: 10/01/23

A Study Comparing Pemetrexed Plus Cisplatin Versus Pemetrexed Alone in NSCLC Patients Who Have Progressed on First Line EGFR-TKI

Phase: N/A Priority: Normal
NCT ID: NCT03050437 Org: User:
Start: 03/31/13 End: 03/31/17 Due: 03/31/18

Genetic Alteration After Systemic Treatment in Breast Cancer

Phase: N/A Priority: Normal
NCT ID: NCT02591966 Org: User:
Start: 01/31/15 End: 12/31/20 Due: 12/31/21